Skip to content
The Atlanta

Study points to copay price as reason people stop taking GLP-1 medication for obesity

Study points to copay price as reason people stop taking GLP-1 medication for obesity
Photo: Rough Draft Atlanta (intown neighborhoods) · view original

Three out of four patients stopped taking their GLP-1 within a year of filling their first prescription even at the lowest cost tier, but researchers saw a significant drop-off around the $75 mark, according to a study published in JAMA Health Forum that analyzed compliance among 8,914 patients w...

Sources and story details